AMICOGEN, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,680 KRW | -1.54% |
|
+2.67% | +1.59% |
| Sales 2022 | 144B 104M 8.69B | Sales 2023 | 160B 115M 9.63B | Capitalization | 412B 298M 24.82B |
|---|---|---|---|---|---|
| Net income 2022 | -47.22B -34.09M -2.84B | Net income 2023 | -23.29B -16.81M -1.4B | EV / Sales 2022 | 3.4 x |
| Net Debt 2022 | 112B 80.67M 6.73B | Net Debt 2023 | 111B 80.17M 6.69B | EV / Sales 2023 | 3.27 x |
| P/E ratio 2022 |
-8.12
x | P/E ratio 2023 |
-13
x | Employees | 216 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.62% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.54% | ||
| 1 week | +2.67% | ||
| Current month | -12.53% | ||
| 1 month | -12.53% | ||
| 3 months | +23.08% | ||
| 6 months | +20.85% | ||
| Current year | +1.59% |
1 week
7 420.00
7 900.00
1 month
6 790.009 200.00
Current year
5 420.009 400.00
1 year
5 420.0010 775.00
3 years
5 420.0023 500.00
5 years
5 200.0024 825.00
10 years
5 200.0031 575.00
| Managers | Title | Age | Since |
|---|---|---|---|
Cheol Park
CEO | Chief Executive Officer | 51 | 13/23/13 |
Yong-Chul Shin
FOU | Founder | 63 | 01/00/01 |
Sang-Hee Lee
DFI | Director of Finance/CFO | 44 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong-Gyun Chung
BRD | Director/Board Member | 63 | - |
Yong-Chul Shin
FOU | Founder | 63 | 01/00/01 |
Tae-Oh Chung
BRD | Director/Board Member | 43 | 26/18/26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 7,680 | -1.54% | 275,110 |
| 29/24/29 | 7,800 | +4.98% | 389,344 |
| 26/24/26 | 7,430 | -2.24% | 396,011 |
| 25/24/25 | 7,600 | -0.78% | 228,552 |
| 24/24/24 | 7,660 | +1.59% | 393,596 |
End-of-day quote Korea S.E., April 30, 2024
More quotes
Amicogen, Inc. is a Korea-based company engaged in the development, production and distribution of enzymes, bio new materials and healthcare food. The Companyâs products consist of special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins. The Company distributes its products within domestic market and to overseas markets, including China, Japan, the United Sates, Germany and Thailand.
Calendar
13/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +1.59% | 304M | |
| -3.46% | 102B | |
| +1.41% | 96.09B | |
| +2.13% | 22.28B | |
| -15.84% | 21.4B | |
| -9.21% | 18.14B | |
| -39.98% | 17.02B | |
| -14.65% | 16.09B | |
| +4.39% | 13.83B | |
| +31.35% | 11.97B |
- Stock Market
- Equities
- A092040 Stock
